Subcutaneous Methylnaltrexone as Treatment for Opioid-Induced Constipation in Patients with Advanced Cancer and Noncancer Illnesses: A Post Hoc Analysis of Two Clinical Trials.

Shah, Eric D; Chamberlain, Bruce H; Rhiner, Michelle; Slatkin, Neil E; Stambler, Nancy; Israel, Robert J

Shah, Eric D; Chamberlain, Bruce H; Rhiner, Michelle; Slatkin, Neil E; Stambler, Nancy; Israel, Robert J.

Afiliación

Shah ED; Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Chamberlain BH; Genesis Healthcare, Davenport, IA, USA.
Rhiner M; Department of Family Medicine, Loma Linda University Health, Loma Linda, CA, USA.
Slatkin NE; School of Medicine, University of California Riverside, Riverside, CA, USA.
Stambler N; Medical Affairs, Salix Pharmaceuticals, Bridgewater, NJ, USA.
Israel RJ; Clinical Research, Progenics Pharmaceuticals, Inc., A Subsidiary of Lantheus Holdings, Inc, New York, NY, USA.

J Pain Res ; 16: 395-406, 2023.

Article en En | MEDLINE | ID: mdl-36798078

Palabras clave

cancer; chronic pain; methylnaltrexone; opioid-induced constipation; µ-opioid receptor antagonist

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: J Pain Res Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google